Follow the Chordia Therapeutics株式会社 share price and the full directors' dealings record of the company, a listed equity based in Japan. Shares trade on the JP market, under the authority of EDINET (Japan FSA). Market capitalisation: €5.5bn. The latest transaction was filed on 16 September 2026 (Holding update). Among the most active insiders: SBI Investment Co., Ltd.. Every trade is openly available.
31
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
24Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,358 of 27,626 companies
6.9
score / 100
Value
6
Quality
7
FCF yld-35%
Earn yld-34%
EV/EBITDA·
ROE-56%
Gross mgn-6.6%
Net mgn-8.3%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.